MARCH 2017 RESEARCH REPORT

Transcription

1 1 MARCH 2017 RESEARCH REPORT LIQUID BIOPSY MARKETS by Lung, Breast, Colorectal, Prostate and Other Including Screening Market Potential Size with Executive and Consultant Guides

2 Liquid Biopsy Markets Page 2 Table of Contents i. Liquid Biopsy Market - Strategic Situation Analysis ii. Guide for Executives, Marketing, Sales and Business Development Staff iii. Guide for Management Consultants and Investment Advisors Introduction and Market Definition What is Liquid Biopsy? The Sequincing Revolution Market Definition Volumes Prices Revenue Market Size Methodology Authors Sources A Spending Perspective on Liquid Biopsy An Historical Look at Clinical Testing Market Overview Players in a Dynamic Market Academic Research Lab Diagnostic Test Developer Genomic Instrumentation Supplier Cell Separation and Viewing Instrumentation Supplier Pharmaceutical/Reagent Supplier Independent Testing Lab Public National/regional lab Hospital lab Physician Lab Audit Body Certification Body Using Biopsies Cancer Precancerous conditions Inflammatory conditions Biopsy Sites The Situation Today Biopsy Analysis Evidence of Cancer - Liquid Biopsy Technology The Big Picture on Liquid Biopsy Technology The Role of CTCs Types of CTCs CellSearch Detection- Ultimate Sensitivity Epic Sciences Detection- Imaging Takes the Lead... 38

3 Liquid Biopsy Markets Page Maintrac Detection The Microscope Other Methods ctdna Going Mainstream? Exosomes and Micro Vesicles New Kid on Block Cancer Treatment Protocol Under Siege Issues and Limitations to Liquid Biopsy Adoption The Cancer Screening Market Opportunity GRAIL What Is It? Cancer Management vs. Diagnosis The Role of Risk Assessment Managing Therapy Monitoring Disease What Is It? Phases of Adoption Looking Into The Future The Promise of Liquid Biopsy Structure of Industry Plays a Part Hospital Testing Share Economies of Scale Hospital vs. Central Lab Physician Office Lab s Physician s and POCT Profiles of Key Players AdnaGen (now Qiagen) Agena Bioscience Angle plc ApoCell Biocept BioFluidica Bio-Rad Laboratories Boreal Genomics Chronix Biomedical Clearbridge BioMedics Cynvenio Cytolumina Technologies Corp CytoTrack Diagnologix LLC Epic Sciences Exosome Diagnostics Exosome Sciences Fluidigm Corp Fluxion Biosciences Genomic Health GRAIL Guardant Health HansaBiomed... 79

4 Liquid Biopsy Markets Page Horizon Discovery icellate Illumina Inivata Janssen Diagnostics Molecular MD Myriad Genetics Natera New Oncology Personal Genome Diagnostics RainDance Technologies Rarecells SAS Silicon Biosystems Sysmex Inostics SRI International Trovagene Market Trends Factors Driving Growth Non Invasive Game Changer Lower Cost Greater Accuracy Wide Range of Potential Uses Aging Population Factors Limiting Growth Lower prices Lack of Standards Protocol Resistance Initial Adoption Has No Cost Savings Instrumentation and Automation Instruments Key to Market Share Bioinformatics Plays a Role Diagnostic Technology Development Next Generation Sequencing Fuels a Revolution Impact of NGS on pricing Pharmacogenomics Blurs Diagnosis and Treatment CGES Testing, A Brave New World Biochips/Giant magneto resistance based assay Liquid Biopsy Recent Developments Recent Developments Importance and How to Use This Section Importance of These Developments How to Use This Section Illumina Forms GRAIL to Enable Early Cancer Detection via Liquid Biopsy ASCO: Researchers Present Advances, Ongoing Challenges in Liquid Biopsy Guardant Health, SWOG Partner on Prospective NSCLC Liquid Biopsy Study

5 Liquid Biopsy Markets Page Qiagen Expands CDx Deal with Tokai; Acquires CTC Assets from AdnaGen Biodesix's GeneStrat Liquid Biopsy Lung Cancer Test Baylor, TGen Collaborate on Personalized Cancer Treatment Options Liquid Biopsy Firm Resolution Bio Gets CLIA Certification for Lab Broad Institute Lands $10M Gift to Study Cancer Drug Resistance Biocept Q1 Revenues Rise With Test Volume Growth CRUK Manchester Institute Joins European Consortium Validating Blood-based Cancer Biomarkers New Oncology Closes Financing Round to Promote Genetic Testing from Blood Cynvenio to present new clinical data EKF, Angle Collaborate for Liquid Biopsy Development Trovagene Collaborates with UCSD for EGFR Monitoring in Lung Cancer AstraZeneca Initiates CDx Partnerships with Roche, Qiagen Horizon, LGC Awarded Research Grant for Cancer Diagnostics Merck Serono and Sysmex Inostics Announce Testing Center Agena Bioscience Launches Smaller Format MassArray Personal Genome Diagnostics Aims for FDA Clearance HTG Molecular Diagnostics Files for IPO of up to $60M Genomic Health Reports 5 Percent Revenue Growth in Third Quarter Biocept, Rosetta Genomics Partner to Profile micrornas from CTCs Inivata Raises $6.6M to Develop ctdna Assays Epic Sciences Raises $30M in Private Financing New Release in Line of Liquid Biopsy CLIA Tests Collaborators Publish Data on Resolution Bio Liquid Biopsy Test Trovagene's Urine-Based Liquid Biopsy Platform Demonstrated in Field FDA Sends Pathway Genomics Untitled Letter Over Liquid Biopsy Test DNA in blood can track cancer development, response in real time Cynvenio Clinical Trial Supports Multi-Template Liquid Biopsy Sequencing Startup AccuraGen to Tap China Liquid Biopsy Market With 61-Gene Assay Sysmex Corporation and Clearbridge BioMedics to Jointly Develop New Liquid Biopsy System MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States GATC Biotech s Liquid Biopsy Testing Takes Cost Lead Liquid Biotech USA, Inc. Announces Completion of Clinical Study Liquid biopsies more effective in some cases than tissue biopsies Cancer Genetics, Inc. and ApoCell Announce Partnership for Rare Cell Capture and Detection Exosome Diagnostics Launches Liquid Biopsy Test to Rule Out High-Grade Prostate Cancer Liquid Biopsy Tests Partially Validated FDA Approves Liquid Biopsy Liquid Biopsy Predicts Colon Cancer Recurrence WaveSense Receives CE-IVD Mark for Cell Enrichment Platform For Liquid Biopsy, Size Matters

6 Liquid Biopsy Markets Page Liquid biopsy startup Freenome lands $5.5 million led by Andreessen Horowitz Trovagene, USC Collaborate on Deployment of Urine-Based Liquid Biopsy Test Circulogene liquid biopsy detects new tumor mass earlier than current imaging methods Clinical Utility of Biocept s Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium Trovagene to Focus More on Liquid Biopsy Testing Market Pancreatic Cancer Gets Prognostic Tool from Liquid Biopsy New Start-up to Work on Scalpel-free Liquid Biopsies A researher at University of California, Berkeley, is launching a start-up called KarnaTeq to develop and market technology to increase the diagnostic power of scalpel-free biopsy Country Market Sizes North America United States of America Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Canada Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Country Markets Europe France Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Germany Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues United Kingdom Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues

7 Liquid Biopsy Markets Page Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Spain Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Italy Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Russia Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Remainder of Europe and Former Soviet Union Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Country Markets Asia Pacific China Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Japan Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues

8 Liquid Biopsy Markets Page Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues South Korea Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues India Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Australia Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Rest of Asia Pacific Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Country Markets Latin America, Africa & The Middle East Brazil Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Mexico Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues

9 Liquid Biopsy Markets Page All Liquid Biopsy Total Volumes, Prices, Revenues Rest of Latin America Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Africa and The Middle East Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Global Market Summary Global Lung Cancer Testing Volumes, Prices, Revenues Breast Cancer Testing Volumes, Prices, Revenues Colorectal Cancer Testing Volumes, Prices, Revenues Prostate Cancer Testing Volumes, Prices, Revenues Other Cancer Testing Volumes, Prices, Revenues All Liquid Biopsy Total Volumes, Prices, Revenues Potential Market Opportunity Sizes Cancer Screening by Country: Lung, Breast & Colorectal Cancer Screening by Country: Prostate, Other Cancer & All Cancer Potential Market Size - Cancer Diagnosis Potential Market Size - Cancer Management Appendices I. United States Medicare System: January 2015 Clinical Laboratory Fees Schedule National Limit and Midpoint II. FDA Approved Human Genetic Tests III. FDA Approved Pharmacogenomics Tests

10 Liquid Biopsy Markets Page 10 Table of Tables Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2020 ($Billion) Table 2 Market Players by Type Table 3 Biopsy Sites Table 4 Advantages of Liquid Biopsy in Screening Market Table 5 Five Factors Driving Growth Table 6 Four Factors Limiting Growth Table 7 Key Diagnostic Laboratory Technology Trends Table 8 Next Generation Sequencing Technologies Speed and Cost Table 9 Lung Cancer Testing - Volume Price and Revenue Forecast Table 10 Breast Cancer Testing - Volume Price and Revenue Forecast Table 11 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 12 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 13 Other Cancer Testing - Volume Price and Revenue Forecast Table 14 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 15 Lung Cancer Testing - Volume Price and Revenue Forecast Table 16 Breast Cancer Testing - Volume Price and Revenue Forecast Table 17 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 18 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 19 Other Cancer Testing - Volume Price and Revenue Forecast Table 20 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 21 Lung Cancer Testing - Volume Price and Revenue Forecast Table 22 Breast Cancer Testing - Volume Price and Revenue Forecast Table 23 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 24 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 25 Other Cancer Testing - Volume Price and Revenue Forecast Table 26 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 27 Lung Cancer Testing - Volume Price and Revenue Forecast Table 28 Breast Cancer Testing - Volume Price and Revenue Forecast Table 29 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 30 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 31 Other Cancer Testing - Volume Price and Revenue Forecast Table 32 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 33 Lung Cancer Testing - Volume Price and Revenue Forecast Table 34 Breast Cancer Testing - Volume Price and Revenue Forecast Table 35 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 36 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 37 Other Cancer Testing - Volume Price and Revenue Forecast Table 38 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 39 Lung Cancer Testing - Volume Price and Revenue Forecast Table 40 Breast Cancer Testing - Volume Price and Revenue Forecast Table 41 Colorectal Cancer Testing - Volume Price and Revenue Forecast

11 Liquid Biopsy Markets Page 11 Table 42 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 43 Other Cancer Testing - Volume Price and Revenue Forecast Table 44 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 45 Lung Cancer Testing - Volume Price and Revenue Forecast Table 46 Breast Cancer Testing - Volume Price and Revenue Forecast Table 47 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 48 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 49 Other Cancer Testing - Volume Price and Revenue Forecast Table 50 All Liquid Biopsy Testing - Volume, Price and Revenue Forecast Table 51 Lung Cancer Testing - Volume Price and Revenue Forecast Table 52 Breast Cancer Testing - Volume Price and Revenue Forecast Table 53 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 54 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 55 Other Cancer Testing - Volume Price and Revenue Forecast Table 56 All Liquid Biopsy - Volume Price and Revenue Forecast Table 57 Lung Cancer Testing - Volume Price and Revenue Forecast Table 58 Breast Cancer Testing - Volume Price and Revenue Forecast Table 59 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 60 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 61 Other Cancer Testing - Volume Price and Revenue Forecast Table 62 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 63 Lung Cancer Testing - Volume Price and Revenue Forecast Table 64 Breast Cancer Testing - Volume Price and Revenue Forecast Table 65 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 66 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 67 Other Cancer Testing - Volume Price and Revenue Forecast Table 68 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 69 Lung Cancer Testing - Volume Price and Revenue Forecast Table 70 Breast Cancer Testing - Volume Price and Revenue Forecast Table 71 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 72 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 73 Other Cancer Testing - Volume Price and Revenue Forecast Table 74 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 75 Lung Cancer Testing - Volume Price and Revenue Forecast Table 76 Breast Cancer Testing - Volume Price and Revenue Forecast Table 77 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 78 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 79 Other Cancer Testing - Volume Price and Revenue Forecast Table 80 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 81 Lung Cancer Testing - Volume Price and Revenue Forecast Table 82 Breast Cancer Testing - Volume Price and Revenue Forecast Table 83 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 84 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 85 Other Cancer Testing - Volume Price and Revenue Forecast

12 Liquid Biopsy Markets Page 12 Table 86 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 87 Lung Cancer Testing - Volume Price and Revenue Forecast Table 88 Breast Cancer Testing - Volume Price and Revenue Forecast Table 89 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 90 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 91 Other Cancer Testing - Volume Price and Revenue Forecast Table 92 All Liquid Biopsy Testing - Volume, Price and Revenue Forecast Table 93 Lung Cancer Testing - Volume Price and Revenue Forecast Table 94 Breast Cancer Testing - Volume Price and Revenue Forecast Table 95 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 96 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 97 Other Cancer Testing - Volume Price and Revenue Forecast Table 98 All Liquid Biopsy - Volume Price and Revenue Forecast Table 99 Lung Cancer Testing - Volume Price and Revenue Forecast Table 100 Breast Cancer Testing - Volume Price and Revenue Forecast Table 101 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 102 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 103 Other Cancer Testing - Volume Price and Revenue Forecast Table 104 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 105 Lung Cancer Testing - Volume Price and Revenue Forecast Table 106 Breast Cancer Testing - Volume Price and Revenue Forecast Table 107 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 108 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 109 Other Cancer Testing - Volume Price and Revenue Forecast Table 110 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 111 Lung Cancer Testing - Volume Price and Revenue Forecast Table 112 Breast Cancer Testing - Volume Price and Revenue Forecast Table 113 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 114 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 115 Other Cancer Testing - Volume Price and Revenue Forecast Table 116 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 117 Lung Cancer Testing - Volume Price and Revenue Forecast Table 118 Breast Cancer Testing - Volume Price and Revenue Forecast Table 119 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 120 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 121 Other Cancer Testing - Volume Price and Revenue Forecast Table 122 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 123 Lung Cancer Testing - Volume Price and Revenue Forecast Table 124 Breast Cancer Testing - Volume Price and Revenue Forecast Table 125 Colorectal Cancer Testing - Volume Price and Revenue Forecast Table 126 Prostate Cancer Testing - Volume Price and Revenue Forecast Table 127 Other Cancer Testing - Volume Price and Revenue Forecast Table 128 All Liquid Biopsy Testing - Volume Price and Revenue Forecast Table 129 Potential Screening Market: Lung, Breast & Colorectal

13 Liquid Biopsy Markets Page 13 Table 130 Potential Screening Market: Prostate, Other & All Table 131 Potential Cancer Diagnosis Market Size Table 132 Potential Cancer Management Market Size Table Clinical Lab Fee Schedule

14 Liquid Biopsy Markets Page 14 Table of Figures Figure 1 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million) Figure 2 Comparison of Liquid Biopsy Classes Figure 3 Characteristics of Different Vesicle Types Figure 4 Percentage of World Population Over